Current role
Biotechnology · Healthcare
Board Member
2023-01-01–present
Martine Zimmermann
Board Member
Ligand Pharmaceuticals Inc (LGND)Equibles does not estimate personal net worth.
Get an email with a short summary when Ligand Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get LGND alertsAbout Martine Zimmermann
Martine Zimmermann is recorded as Board Member at Ligand Pharmaceuticals Inc (LGND) since January 1, 2023. The newest filing on record that lists Martine Zimmermann as Board Member at Ligand Pharmaceuticals Inc (LGND) is dated April 21, 2026. Ligand Pharmaceuticals Inc reported in an 8-K filed June 17, 2024 that Martine Zimmermann was appointed director. Ligand Pharmaceuticals Inc reported in an 8-K filed September 27, 2023 that Martine Zimmermann was appointed member of Board, effective September 22, 2023. Ligand Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ligand Pharmaceuticals Inc includes Todd C. Davis (CEO and Board Member), Tavo Espinoza (CFO), Jason Haas (Board Member) and 7 others.
“each nominee was elected to serve as a director of the Company.”
“On September 22, 2023, the board of directors (the “Board”) of Ligand Pharmaceuticals Incorporated (the “Company”) appointed Martine Zimmermann as a member of Board.”
Affiliation history
-
Current
2023-01-01–present
Last confirmed April 21, 2026
Company network
Leadership on record at Ligand Pharmaceuticals Inc
- Todd C. Davis CEO, Board Member
- Tavo Espinoza CFO
- Jason Haas Board Member
- Jason M. Aryeh Board Member
- Jennifer Cochran, Ph.D. Board Member
- John L. LaMattina Board Member
- John L. LaMattina, Ph.D. Board Member
- John W. Kozarich Board Member
- John W. Kozarich, Ph.D. Board Member
- Martine Zimmermann, Pharm.D. Board Member